RhD-positive red blood cell allocation practice to RhD-negative patients before and during the COVID-19 pandemic
Despite RhD-negative pRBC supply challenges, most institutional policies and personal practices on when to provide RhD-positive pRBCs to RhD-negative patients did not change during the pandemic.
Authors
- Yvette C. Tanhehco (ORCID: https://orcid.org/0000-0002-7800-3119)
- Wen Lu (ORCID: https://orcid.org/0000-0003-2292-3167)
- Daniela Hermelin (ORCID: https://orcid.org/0000-0001-9099-6021)
- Mark Fung (ORCID: https://orcid.org/0000-0001-6081-4151)
- Jennifer Becker (ORCID: https://orcid.org/0009-0004-8554-4281)
Institutions
- Mayo Clinic (US)
- University of Nevada, Reno (US)
- Saint Louis University (ES)
- Columbia University Irving Medical Center (US)
- University of Vermont Medical Center (US)
- Davenport University (US)
- Mayo Clinic in Arizona (US)
- Saint Louis University (US)
Publication Details
- Journal
- American Journal of Clinical Pathology
- Published
- 2024-09-17
- DOI
- https://doi.org/10.1093/ajcp/aqae113
- Primary Topic
- Blood groups and transfusion
- Type
- article
- Field-Weighted Citation Impact
- 0.00